Skip to main content
VCbacked
Log inGet Started

OncoMyx Therapeutics

Phoenix, United States

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

$50.0M raised
Dec 2021
Series B
BiotechnologyHealth DiagnosticsMedicalTherapeutics

Top Investors

B CapitalBoehringer Ingelheim Venture FundLumira VenturesDelos CapitalKorea Investment Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OncoMyx Therapeutics

How much funding has OncoMyx Therapeutics raised?
OncoMyx Therapeutics has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Who are OncoMyx Therapeutics's investors?
OncoMyx Therapeutics's investors include B Capital, Boehringer Ingelheim Venture Fund, Lumira Ventures, Delos Capital, Korea Investment Partners.
Where is OncoMyx Therapeutics headquartered?
OncoMyx Therapeutics is headquartered in Phoenix, United States.
What does OncoMyx Therapeutics do?
OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.
What stage is OncoMyx Therapeutics at?
OncoMyx Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"OncoMyx Therapeutics — Funding & Investors." VCBacked, December 9, 2021, https://www.vcbacked.co/company/oncomyx-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). OncoMyx Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oncomyx-therapeutics
Wikipedia (cite web)
{{cite web |title=OncoMyx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oncomyx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K